C3G research hub

An Open-Label, Nonrandomized, Multicenter Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan in Participants With C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis

This study looks at the long-term effects of a medicine called pegcetacoplan for kidney conditions like C3 Glomerulopathy (C3G) and IC-MPGN. It's for people who were in a previous study and seemed to benefit from the treatment.